Toggle navigation
Home
About Wayshine
About Us
Our People
Our Science
Pipeline
Clinical Trials
WSD0922 PhaseIIa
WSD0922-102 Phase I/II
WSD0922-103 Phase I
WS2202 Phase II
WSD0628 Phase I
Media
Media Release
Events
Job Vacancy
Contact us
中文
CTR20252651
一项评估WSD0922-FU用于治疗一线奥希替尼治疗后疾病进展且肿瘤携带表皮生长因子受体基因C797S 突变的局部晚期或转移性非小细胞肺腺癌受试者的开放标签、国际多中心、单臂II 期临床研究
https://www.chinadrugtrials.org.cn/clinicaltrials.prosearch.dhtml
Contact: Wayshine Biopharm
Address：Room 903, Chenkai International Building, No. 355 Hongqiao Road, Xuhui District, Shanghai
Mail：wsd@wayshinebiopharm.com
About Wayshine
About Us
Our People
Our Science
WeChat Official Account
Copyright © 2026 Wayshine Biopharm International Ltd. Cayman
